离体切除与肠道自体移植:国际多中心研究
该国际多中心回顾性研究分析了1999至2024年间5家机构35例接受离体切除与肠道自体移植(ERIA)的肿瘤患者,其中25例行Whipple手术。结果显示90天死亡率为0,R0切除率85.7%,总体1、3、5年生存率分别为87.7%、70.3%、66.2%。高恶性组与良性/低度恶性组生存差异明显。
要点
- ERIA术后90天死亡率为0,R0切除率85.7%。
- 总体1、3、5年生存率分别为87.7%、70.3%、66.2%。
- 高恶性组5年OS为32.5%,良性/低度恶性组为92.9%。
核心结论
- ERIA可在经过选择的常规方法不可切除肿瘤患者中实施,围术期死亡率低且结局可接受。
研究设计与样本
- 国际多中心回顾性数据分析,纳入1999至2024年间5家机构接受ERIA(伴或不伴Whipple手术)的患者,排除需肝自体移植者,共35例。
主要发现
- 共35例患者,其中25例行Whipple手术;肿瘤分为高恶性组16例和良性/低度恶性组19例。
- 中位肿瘤大小11.1 cm(范围4.5-30.0 cm),R0切除率85.7%,90天死亡率为0。
- 总体1、3、5年生存率分别为87.7%、70.3%、66.2%。
- 高恶性组1、3、5年OS分别为72.2%、32.5%、32.5%,RFS分别为66.7%、20.0%、13.3%。
- 良性/低度恶性组1、3、5年OS分别为100%、100%、92.9%,RFS分别为100%、93.3%、86.7%。
临床怎么用
- 对于常规方法不可切除的肠道相关肿瘤,可考虑在经验丰富的中心评估ERIA的可行性。
局限性
- 回顾性研究,样本量较小(35例),存在选择偏倚可能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the perioperative and long-term outcomes of ex vivo resection and intestinal autotransplantation (ERIA) for tumors. SUMMARY OF BACKGROUND DATA: ERIA could offer effective therapy for tumors considered unresectable by conventional methods. However, there has been limited data of ERIA. To our knowledge, this represents the largest case series of ERIA to date. METHODS: We conducted an international multicenter retrospective data analysis of patients who underwent ERIA with or without Whipple procedure at 5 institutions between 1999 and 2024. Cases that required liver autotransplantation were excluded. RESULTS: A total of 35 patients (25 with Whipple procedures) were analyzed. We classified tumors as highly malignant (n=16) and benign/low-grade (n=19). The highly malignant group included 7 pancreatic adenocarcinomas and 5 sarcomas, while the low-grade group included 9 desmoid tumors. The median tumor size was 11.1 cm (4.5-30.0 cm) and R0 resection was achieved in 85.7%. There was no 90-day mortality. The overall 1-, 3-, and 5-year survivals were 87.7, 70.3, and 66.2%, respectively. The 1, 3, and 5 year overall survival (OS) and recurrence-free survival (RFS) for the highly malignant group were 72.2%, 32.5%, and 32.5% and 66.7%, 20.0%, and 13.3%, respectively. The 1, 3, and 5 year OS and RFS for the benign to low-grade tumors were 100%, 100%, and 92.9% and 100%, 93.3%, and 86.7%, respectively. CONCLUSIONS: ERIA can be performed with low perioperative mortality and acceptable outcomes in select patients with otherwise unresectable tumors.
引用
- Fujiwara S, Tekin A, Pinna AD, et al. Ex Vivo Resection and Intestinal Autotransplantation: An International Multicenter Study. Ann Surg. 2025. PMID: 40747941. doi:10.1097/SLA.0000000000006874
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。